Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metabolic profiles of regulatory T cells and their adaptations to the tumor microenvironment: implications for antitumor immunity
Yuheng Yan, Lan Huang, Yiming Liu, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 108

Showing 1-25 of 108 citing articles:

Ferroptosis in cancer: From molecular mechanisms to therapeutic strategies
Qian Zhou, Yu Meng, Daishi Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 133
Lipid metabolic reprogramming in tumor microenvironment: from mechanisms to therapeutics
Hao-Ran Jin, Jin Wang, Zijing Wang, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 123
Nanomaterials in tumor immunotherapy: new strategies and challenges
Xudong Zhu, Shenglong Li
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 101
Exploiting innate immunity for cancer immunotherapy
Ming Yi, Tianye Li, Mengke Niu, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 78
Effects of dietary intervention on human diseases: molecular mechanisms and therapeutic potential
Yu-Ling Xiao, Yue Gong, Ying-Jia Qi, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 60
Focal adhesion kinase: from biological functions to therapeutic strategies
Ximin Tan, Yuheng Yan, Bin Song, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 51
Targeting TIGIT for cancer immunotherapy: recent advances and future directions
Peng Zhang, Xinyuan Liu, Zhuoyu Gu, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 28
Immunosuppressive tumor microenvironment in the progression, metastasis, and therapy of hepatocellular carcinoma: from bench to bedside
Yue Yin, Weibo Feng, Jie Chen, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 18
Tumor microenvironment targeted nano-drug delivery systems for multidrug resistant tumor therapy
Xinyue Shao, Xiaoling Zhao, Binghao Wang, et al.
Theranostics (2025) Vol. 15, Iss. 5, pp. 1689-1714
Open Access | Times Cited: 2
Targeting lipid metabolism in regulatory T cells for enhancing cancer immunotherapy
Yang Liu, Xingyue Wang, Shu‐Rong Wang, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189259-189259
Open Access | Times Cited: 2
Nasopharyngeal carcinoma cells promote regulatory T cell development and suppressive activity via CD70-CD27 interaction
Lanqi Gong, Jie Luo, Yu Zhang, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 39
Nanomaterials: Breaking through the bottleneck of tumor immunotherapy
Yue Kang, Shenglong Li
International Journal of Biological Macromolecules (2023) Vol. 230, pp. 123159-123159
Closed Access | Times Cited: 36
Inhibition of glycolysis-driven immunosuppression with a nano-assembly enhances response to immune checkpoint blockade therapy in triple negative breast cancer
Xijiao Ren, Zhuo Cheng, Jinming He, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 34
Lipid metabolism reprogramming of CD8+ T cell and therapeutic implications in cancer
Runxian Wang, Zhenya Liu, Zhiyao Fan, et al.
Cancer Letters (2023) Vol. 567, pp. 216267-216267
Closed Access | Times Cited: 32
Vaping, Environmental Toxicants Exposure, and Lung Cancer Risk
Shaimaa A. Shehata, Eman A. Toraih, Ezzat A. Ismail, et al.
Cancers (2023) Vol. 15, Iss. 18, pp. 4525-4525
Open Access | Times Cited: 27
Antibody-based cancer immunotherapy by targeting regulatory T cells
Quanxiao Li, Jun Lu, Jinyao Li, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 23
Recent progress in nanocarrier-based drug delivery systems for antitumour metastasis
Shan Peng, Xiaomeng Yuan, Hongjie Li, et al.
European Journal of Medicinal Chemistry (2023) Vol. 252, pp. 115259-115259
Closed Access | Times Cited: 22
Targeting tumor-infiltrating tregs for improved antitumor responses
Diyuan Qin, Yugu Zhang, Pei Shu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 14
Metabolic reprogramming and immune evasion: the interplay in the tumor microenvironment
Haixia Zhang, Shizhen Li, Dan Wang, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 14
Tumor battlefield within inflamed, excluded or desert immune phenotypes: the mechanisms and strategies
Siwei Zheng, Wenwen Wang, Lesang Shen, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 13
Regulatory T cells in immune checkpoint blockade antitumor therapy
An Zhang, Tao Fan, Yixiao Liu, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 12
The potential and promise for clinical application of adoptive T cell therapy in cancer
Yinqi Li, Yeteng Zheng, Taiqing Liu, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 11
Tumor metabolic regulators: key drivers of metabolic reprogramming and the promising targets in cancer therapy
Kun Huang, Ying Han, Yihong Chen, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Integrating single-cell RNA-seq and bulk RNA-seq to construct prognostic signatures to explore the role of glutamine metabolism in breast cancer
Shengbin Pei, Pengpeng Zhang, Huilin Chen, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 21
Recent advances in ocular graft-versus-host disease
Xianjing Cheng, Ruihao Huang, Shiqin Huang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 20
Page 1 - Next Page

Scroll to top